Attached files
file | filename |
---|---|
10-Q - AEOLUS PHARMACEUTICALS, INC. | v210878_10q.htm |
EX-31.1 - AEOLUS PHARMACEUTICALS, INC. | v210878_ex31-1.htm |
EX-31.2 - AEOLUS PHARMACEUTICALS, INC. | v210878_ex31-2.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18
U.S.C. SECTION 1350)
In
connection with the Quarterly Report of Aeolus Pharmaceuticals, Inc. (the
“Company”) on Form 10-Q for the period ended December 31, 2010, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), the
undersigned, John L. McManus, Principal Executive Officer and Principal
Financial and Accounting Officer of the Company certifies pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of his knowledge:
1.
|
The Report fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and
|
2.
|
The information contained in the
Report fairly presents, in all material respects, the financial condition
and results of operations of the
Company.
|
Date:
February 10, 2011
|
|
/s/ John L. McManus
|
|
John
L. McManus
|
|
President
and Chief Executive Officer
|
|
(Principal
Executive Officer)
|
Date:
February 10, 2011
|
|
/s/ John L. McManus
|
|
John
L. McManus
|
|
Principal
Financial and Accounting Officer
|
THIS
CERTIFICATION “ACCOMPANIES” THE QUARTERLY REPORT, IS NOT DEEMED FILED WITH THE
SEC AND IS NOT TO BE INCORPORATED BY REFERENCE INTO ANY FILING OF THE COMPANY
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES EXCHANGE ACT OF
1934, AS AMENDED (WHETHER MADE BEFORE OR AFTER THE DATE OF THE ANNUAL REPORT),
IRRESPECTIVE OF ANY GENERAL INCORPORATION LANGUAGE CONTAINED IN SUCH
FILING. A SIGNED ORIGINAL OF THIS CERTIFICATION HAS BEEN PROVIDED TO THE
COMPANY AND WILL BE RETAINED BY THE COMPANY AND FURNISHED TO THE SECURITIES AND
EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.